cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Immunitybio Inc
17 own
6 watching
Current Price
$4.92
$-0.32
(-6.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,586.57M
52-Week High
52-Week High
6.93000
52-Week Low
52-Week Low
1.25000
Average Volume
Average Volume
2.87M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,586.57M
icon52-Week High6.93000
icon52-Week Low1.25000
iconAverage Volume2.87M
iconDividend Yield--
iconP/E Ratio--
What does the Immunitybio Inc do?
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
Read More
How much money does Immunitybio Inc make?
News & Events about Immunitybio Inc.
Globe Newswire
9 months ago
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLPreminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between May 23, 2022 and May 10, 2023. ImmunityBio is a clinical-...
Globe Newswire
9 months ago
ATLANTA, July 05, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that it has filed a class action lawsuit against ImmunityBio, Inc. (ImmunityBio,or the Company) (NASDAQ: IBRX). The lawsuit alleges ImmunityBio made materially false and/or misleading statements and/or failed to ...
PR Newswire
9 months ago
Calling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! Calling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! PR Newswire NEW YORK, July 5, 2023 NEW YORK, July 5, 2023 /PRNewswire/ -- Attorney...
Business Wire
9 months ago
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, both dates inclusive (the Class Period). A class action lawsuit has already been...
Globe Newswire
9 months ago
SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022 May 10, 2023Lead Plaintiff Deadline: Aug. 29, 2023Visit: www.hbsslaw.com/investor-fraud/IBRX Contact ...
Frequently Asked Questions
Frequently Asked Questions
What is Immunitybio Inc share price today?
plus_minus_icon
Can Indians buy Immunitybio Inc shares?
plus_minus_icon
How can I buy Immunitybio Inc shares from India?
plus_minus_icon
Can Fractional shares of Immunitybio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Immunitybio Inc stocks?
plus_minus_icon
What is today’s traded volume of Immunitybio Inc?
plus_minus_icon
What is today’s market capitalisation of Immunitybio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Immunitybio Inc?
plus_minus_icon
What percentage is Immunitybio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Immunitybio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.92
$-0.32
(-6.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00